skip to main content
Idioma:

Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis

Oliveira, Vitor H F ; Borsari, Ana L ; Webel, Allison R ; Erlandson, Kristine M ; Deminice, Rafael

European journal of clinical nutrition, 2020-07, Vol.74 (7), p.1009-1021 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
  • Título:
    Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis
  • Autor: Oliveira, Vitor H F ; Borsari, Ana L ; Webel, Allison R ; Erlandson, Kristine M ; Deminice, Rafael
  • Assuntos: Analysis ; Health risks ; HIV ; HIV (Viruses) ; Human immunodeficiency virus ; Meta-analysis ; Minority & ethnic groups ; Muscles ; Risk analysis ; Risk factors ; Sarcopenia ; Sexually transmitted diseases ; STD ; Tobacco ; Viruses
  • É parte de: European journal of clinical nutrition, 2020-07, Vol.74 (7), p.1009-1021
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Feature-1
    ObjectType-Review-4
    content type line 23
    ObjectType-Undefined-3
  • Descrição: People living with HIV (PLHIV) experience greater loss of muscle mass and function than people without HIV. However, HIV is not routinely recognized as a sarcopenia risk factor outside of HIV literature. The purposes of this study were to establish the prevalence and predictors of sarcopenia among PLHIV, and to compare the prevalence of sarcopenia among PLHIV and people without HIV. A systematic literature search of the PubMed, Embase, Cinahl, and Scielo databases was performed following PRISMA and MOOSE guidelines. Identified articles were included if they evaluated sarcopenia among PLHIV using either the presence of low muscle mass only or low muscle mass in association with low muscle function. The pooled prevalence of sarcopenia among PLHIV and the odds ratio for sarcopenia in PLHIV compared with controls were calculated. From 13 studies and 2267 participants, the prevalence of sarcopenia among PLHIV was 24.1% (95% CI = 17.8-31.0%). PLHIV presented 6.1 greater odds (95% CI = 1.1-33.5) of sarcopenia compared with people without HIV, matched by age, sex, BMI, and ethnicity. Longer exposure to specific HIV drugs, tobacco and alcohol, lower education and employment rates, and greater HIV duration were associated with sarcopenia. In conclusion, PLHIV had a high prevalence of sarcopenia, related to both HIV and non-HIV risk factors. HIV should be considered a risk factor for sarcopenia in the general population. CRD42019131449.
  • Editor: England: Nature Publishing Group
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.